|
[1]
|
Al‐Hamadani, M., Habermann, T.M., Cerhan, J.R., Macon, W.R., Maurer, M.J. and Go, R.S. (2015) Non‐Hodgkin Lymphoma Subtype Distribution, Geodemographic Patterns, and Survival in the US: A Longitudinal Analysis of the National Cancer Data Base from 1998 to 2011. American Journal of Hematology, 90, 790-795. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Sehn, L.H. and Salles, G. (2021) Diffuse Large B-Cell Lymphoma. New England Journal of Medicine, 384, 842-858. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kakulas, B.A. and Finlay-Jones, L.R. (1962) A Lymphoma with Central Nervous System Involvement. Neurology, 12, 495-495. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Ma, J., Li, Q., Shao, J., Ma, Y., Lin, Z., Kang, H., et al. (2019) central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study. Cancer Management and Research, 11, 10175-10185. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
El-Galaly, T.C., Cheah, C.Y., Bendtsen, M.D., Nowakowski, G.S., Kansara, R., Savage, K.J., et al. (2018) Treatment Strategies, Outcomes and Prognostic Factors in 291 Patients with Secondary CNS Involvement by Diffuse Large B-Cell Lymphoma. European Journal of Cancer, 93, 57-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Simard, J. and Roschewski, M. (2022) SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS Lymphoma. Clinical Lymphoma Myeloma and Leukemia, 22, 709-717. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Thiele, B., Binder, M., Schliffke, S., Frenzel, C., Dierlamm, J., Wass, M., et al. (2021) Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation. Oncology Research and Treatment, 44, 375-381. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Villano, J.L., Koshy, M., Shaikh, H., Dolecek, T.A. and McCarthy, B.J. (2011) Age, Gender, and Racial Differences in Incidence and Survival in Primary CNS Lymphoma. British Journal of Cancer, 105, 1414-1418. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Malikova, H., Burghardtova, M., Koubska, E., Mandys, V., Kozak, T. and Weichet, J. (2018) Secondary Central Nervous System Lymphoma: Spectrum of Morphological MRI Appearances. Neuropsychiatric Disease and Treatment, 14, 733-740. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Bathla, G. and Hegde, A. (2016) Lymphomatous Involvement of the Central Nervous System. Clinical Radiology, 71, 602-609. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kaulen, L.D., Galluzzo, D., Hui, P., Barbiero, F., Karschnia, P., Huttner, A., et al. (2019) Prognostic Markers for Immunodeficiency-Associated Primary Central Nervous System Lymphoma. Journal of Neuro-Oncology, 144, 107-115. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Haldorsen, I.S., Espeland, A. and Larsson, E.-M. (2010) Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging. American Journal of Neuroradiology, 32, 984-992. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Villa, D., Connors, J.M., Shenkier, T.N., Gascoyne, R.D., Sehn, L.H. and Savage, K.J. (2010) Incidence and Risk Factors for Central Nervous System Relapse in Patients with Diffuse Large B-Cell Lymphoma: The Impact of the Addition of Rituximab to CHOP Chemotherapy. Annals of Oncology, 21, 1046-1052. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Gleeson, M., Counsell, N., Cunningham, D., Chadwick, N., Lawrie, A., Hawkes, E.A., et al. (2017) Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma in the Rituximab Era: Results of the UK NCRI R-CHOP-14 versus 21 Trial. Annals of Oncology, 28, 2511-2516. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Appaduray, S.P., Khoo, J., Somasundaram, N., Chan, J. and Yan, S.X. (2020) Early Detection of Secondary Central Nervous System Lymphoma on PET/CT. Clinical Nuclear Medicine, 45, e254-e257. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Bobillo, S., Khwaja, J., Ferreri, A.J. and Cwynarski, K. (2022) Prevention and Management of Secondary Central Nervous System Lymphoma. Haematologica, 108, 673-689. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Giannini, C., Dogan, A. and Salomão, D.R. (2014) CNS Lymphoma: A Practical Diagnostic Approach. Journal of Neuropathology & Experimental Neurology, 73, 478-494. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Chiavazza, C., Pellerino, A., Ferrio, F., Cistaro, A., Soffietti, R. and Rudà, R. (2018) Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring. BioMed Research International, 2018, Article ID: 3606970. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Law, M., Yang, S., Wang, H., et al. (2003) Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging. AJNR American Journal of Neuroradiology, 24, 1989-1998.
|
|
[20]
|
Calli, C., Kitis, O., Yunten, N., Yurtseven, T., Islekel, S. and Akalin, T. (2006) Perfusion and Diffusion MR Imaging in Enhancing Malignant Cerebral Tumors. European Journal of Radiology, 58, 394-403. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Faehndrich, J., Weidauer, S., Pilatus, U., Oszvald, A., Zanella, F.E. and Hattingen, E. (2011) Neuroradiological Viewpoint on the Diagnostics of Space-Occupying Brain Lesions. Clinical Neuroradiology, 21, 123-139. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Hwang, T., Close, T.P., Grego, J.M., Brannon, W.L. and Gonzales, F. (1996) Predilection of Brain Metastasis in Gray and White Matter Junction and Vascular Border Zones. Cancer, 77, 1551-1555. [Google Scholar] [CrossRef]
|
|
[23]
|
Fink, K. and Fink, J. (2013) Imaging of Brain Metastases. Surgical Neurology International, 4, S209-S219. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Starr, C.J. and Cha, S. (2017) Meningioma Mimics: Five Key Imaging Features to Differentiate Them from Meningiomas. Clinical Radiology, 72, 722-728. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Hardy, T.A. and Chataway, J. (2013) Tumefactive Demyelination: An Approach to Diagnosis and Management. Journal of Neurology, Neurosurgery & Psychiatry, 84, 1047-1053. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Altintas, A., Petek, B., Isik, N., Terzi, M., Bolukbasi, F., Tavsanli, M., et al. (2012) Clinical and Radiological Characteristics of Tumefactive Demyelinating Lesions: Follow-Up Study. Multiple Sclerosis Journal, 18, 1448-1453. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Sánchez, P., Chan, F. and Hardy, T.A. (2021) Tumefactive Demyelination: Updated Perspectives on Diagnosis and Management. Expert Review of Neurotherapeutics, 21, 1005-1017. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Bernardini, G.L. (2004) Diagnosis and Management of Brain Abscess and Subdural Empyema. Current Neurology and Neuroscience Reports, 4, 448-456. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Muccio, C.F., Caranci, F., D’Arco, F., Cerase, A., De Lipsis, L., Esposito, G., et al. (2014) Magnetic Resonance Features of Pyogenic Brain Abscesses and Differential Diagnosis Using Morphological and Functional Imaging Studies: A Pictorial Essay. Journal of Neuroradiology, 41, 153-167. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Baraniskin, A., Deckert, M., Schulte‐Altedorneburg, G., Schlegel, U. and Schroers, R. (2011) Current Strategies in the Diagnosis of Diffuse Large B‐Cell Lymphoma of the Central Nervous System. British Journal of Haematology, 156, 421-432. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Provenzale, J.M., Joseph, G.J. and Barboriak, D.P. (1998) Dural Sinus Thrombosis: Findings on CT and MR Imaging and Diagnostic Pitfalls. American Journal of Roentgenology, 170, 777-783. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Li, L., Leung, G.K., Ho, R.S. and Lui, W. (2015) Recurrent Natural Killer Cell Lymphoma with Central Nervous System Metastasis Mimicking Cerebellar Infarction. World Neurosurgery, 84, 2074.e5-2074.e9. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Greschus, S., Kuchelmeister, K., Oeynhausen, S., Fischer, H.P. and Urbach, H. (2013) Cerebral Tuberculoma Mimicking Brain Tumor. Clinical Neuroradiology, 24, 389-393. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Khatri, G.D., Krishnan, V., Antil, N. and Saigal, G. (2018) Magnetic Resonance Imaging Spectrum of Intracranial Tubercular Lesions: One Disease, Many Faces. Polish Journal of Radiology, 83, 628-639. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
DeLance, A.R., Safaee, M., Oh, M.C., Clark, A.J., Kaur, G., Sun, M.Z., et al. (2013) Tuberculoma of the Central Nervous System. Journal of Clinical Neuroscience, 20, 1333-1341. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Liu, Z., Wen, G., Huang, Y., Dong, Y., Wang, Z., Alhaskawi, A., et al. (2023) [18F]AlF-NOTA-ADH-1: A New PET Molecular Radiotracer for Imaging of N-Cadherin-Positive Tumors. Frontiers in Oncology, 13, Article ID: 1126721. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Iancu, S.D., Albu, C., Chiriac, L., Moldovan, R., Stefancu, A., Moisoiu, V., et al. (2020) Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies. International Journal of Nanomedicine, 15, 4811-4824. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Marzola, P., Busato, A., Bonafede, R., Bontempi, P., Scambi, I., Schiaffino, L., et al. (2016) Magnetic Resonance Imaging of Ultrasmall Superparamagnetic Iron Oxide-Labeled Exosomes from Stem Cells: A New Method to Obtain Labeled Exosomes. International Journal of Nanomedicine, 11, 2481-2490. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Lohmann, P., Werner, J., Shah, N.J., Fink, G.R., Langen, K. and Galldiks, N. (2019) Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients. Cancers, 11, Article No. 153. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Shah, T. and Venur, V.A. (2023) Central Nervous System Lymphoma. Seminars in Neurology, 43, 825-832. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Ghose, A., Elias, H.K., Guha, G., Yellu, M., Kundu, R. and Latif, T. (2015) Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis—A Systematic Review of Prospective Studies. Clinical Lymphoma Myeloma and Leukemia, 15, 451-457. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Savage, K.J., Slack, G.W., Mottok, A., Sehn, L.H., Villa, D., Kansara, R., et al. (2016) Impact of Dual Expression of MYC and BCL2 by Immunohistochemistry on the Risk of CNS Relapse in DLBCL. Blood, 127, 2182-2188. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
El-Galaly, T.C., Villa, D., Michaelsen, T.Y., Hutchings, M., Mikhaeel, N.G., Savage, K.J., et al. (2017) The Number of Extranodal Sites Assessed by PET/CT Scan Is a Powerful Predictor of CNS Relapse for Patients with Diffuse Large B-Cell Lymphoma: An International Multicenter Study of 1532 Patients Treated with Chemoimmunotherapy. European Journal of Cancer, 75, 195-203. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Schmitz, N., Zeynalova, S., Nickelsen, M., Kansara, R., Villa, D., Sehn, L.H., et al. (2016) CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-Chop. Journal of Clinical Oncology, 34, 3150-3156. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Peñalver, F., Sancho, J., de la Fuente, A., Olave, M., Martín, A., Panizo, C., et al. (2016) Guidelines for Diagnosis, Prevention and Management of Central Nervous System Involvement in Diffuse Large B-Cell Lymphoma Patients by the Spanish Lymphoma Group (Geltamo). Haematologica, 102, 235-245. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Cox, M.C., Di Napoli, A., Scarpino, S., Salerno, G., Tatarelli, C., Talerico, C., et al. (2014) Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IGM Component. PLOS ONE, 9, e93903. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Krsmanovic, P., Mocikova, H., Chramostova, K., Klanova, M., Trnkova, M., Pesta, M., et al. (2022) Circulating MicroRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas. Cancers, 14, Article No. 2305. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Hiemcke‐Jiwa, L.S., Minnema, M.C., Radersma‐van Loon, J.H., Jiwa, N.M., de Boer, M., Leguit, R.J., et al. (2017) The Use of Droplet Digital PCR in Liquid Biopsies: A Highly Sensitive Technique for MYD88 p.(L265P) Detection in Cerebrospinal Fluid. Hematological Oncology, 36, 429-435. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Savage, K.J. (2017) Secondary CNS Relapse in Diffuse Large B-Cell Lymphoma: Defining High-Risk Patients and Optimization of Prophylaxis Strategies. Hematology, 2017, 578-586. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Puckrin, R., El Darsa, H., Ghosh, S., Peters, A., Owen, C. and Stewart, D. (2021) Ineffectiveness of High‐Dose Methotrexate for Prevention of CNS Relapse in Diffuse Large B‐Cell Lymphoma. American Journal of Hematology, 96, 764-771. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Orellana-Noia, V.M., Reed, D.R., McCook, A.A., Sen, J.M., Barlow, C.M., Malecek, M., et al. (2022) Single-Route CNS Prophylaxis for Aggressive Non-Hodgkin Lymphomas: Real-World Outcomes from 21 US Academic Institutions. Blood, 139, 413-423. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Lewis, K.L., Chin, C.K., Manos, K., Casey, J., Hamad, N., Crawford, J., et al. (2020) Ibrutinib for Central Nervous System Lymphoma: The Australasian Lymphoma Alliance/MD Anderson Cancer Center Experience. British Journal of Haematology, 192, 1049-1053. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Ayed, A.O., Chiappella, A., Pederson, L., Laplant, B.R., Congiu, A.G., Gaidano, G., et al. (2018) CNS Relapse in Patients with DLBCL Treated with Lenalidomide Plus R-CHOP (R2CHOP): Analysis from Two Phase 2 Studies. Blood Cancer Journal, 8, Article No. 63. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Perry, C., Ben Barouch, S., Goldschmidt, N., Sarid, N., Herishanu, Y., Shvidel, L., et al. (2019) Characteristics, Management and Outcome of DLBCL Patients, Presenting with Simultaneous Systemic and CNS Disease at Diagnosis: A Retrospective Multicenter Study. American Journal of Hematology, 94, 992-1001. [Google Scholar] [CrossRef] [PubMed]
|